Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease [Phase 2]
Phase 2 trial evaluating an umbilical cord blood transplant regimen with cyclophosphamide, fludarabine, and total-body irradiation for hemat…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies [Phase 2]
Phase 2 trial evaluating reduced-intensity conditioning with fludarabine and melphalan plus total body irradiation for haploidentical stem c…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Study of Copanlisib and Ketogenic Diet [Phase 2]
A Phase 2 study evaluating copanlisib in combination with a ketogenic diet for follicular lymphoma and endometrial cancer was terminated, wi…
-
FDA approval · 2025-03-03FDA Approved: LENALIDOMIDE — Original Application (BIOCON PHARMA INC.,)
FDA approved Biocon Pharma Inc.'s lenalidomide as an original ANDA, enabling a generic version of the cancer drug. Indications include multi…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: CD70-targeted immunoPET Imaging of Malignant Cancers [NA]
A clinical trial evaluating CD70-targeted immunoPET imaging in multiple cancers is currently recruiting, including renal cell carcinoma, dif…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies [Phase 1]
Phase 1 clinical trial update for BP1002 in advanced lymphoid malignancies across several B-cell and T-cell lymphomas; trial status is activ…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
A recruiting clinical study assessing lisocabtagene maraleucel (Liso-cel) for relapsed/refractory follicular lymphoma in the post‑marketing …
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL [Phase 2]
A Phase 2 clinical trial evaluating lenalidomide in combination with G-CHOP for newly diagnosed diffuse large B-cell lymphoma with follicula…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma [Phase 2]
Phase 2 clinical trial evaluating chidamide in combination with linperlisib for refractory/relapsed follicular lymphoma is currently recruit…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma [Phase 2]
Phase 2 trial of axicabtagene ciloleucel for relapsed/refractory follicular lymphoma, currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma [NA]
A prospective analysis of circulating nucleosomes in patients receiving first-line treatment for non-Hodgkin lymphoma, including Follicular …
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Rituximab + Immunotherapy in Follicular Lymphoma [Phase 1]
Phase 1 trial of Rituximab plus immunotherapy in follicular lymphoma was terminated. Results were posted on 2025-02-06.
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies [Phase 1]
Phase 1 VENOM trial evaluating venetoclax with obinutuzumab and magrolimab in relapsed and refractory indolent B-cell malignancies has compl…
-
CLINICAL_TRIALS withdrawal · 2025-02-03Clinical Trial Update: Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma [Phase 1]
A Phase 1 clinical study evaluating duvortuxizumab plus ibrutinib in lymphomas has been withdrawn.
-
FDA approval · 2025-01-31FDA Approved: LENALIDOMIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's generic lenalidomide (LENALIDOMIDE) under an Original Application (ANDA 216213).
-
CLINICAL_TRIALS safety_alert · 2025-01-24Clinical Trial Update: A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma [Phase 2]
An update on a Phase 2 study evaluating adverse events of subcutaneous epcoritamab in adults with relapsed or refractory diffuse large B-cel…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)
This clinical trial update reports on signatures of response and resistance to mosunetuzumab in follicular lymphoma.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Tazemetostat for the Treatment of Relapsed/Refractory Follicular Lymphoma [Phase 2]
A Phase 2 trial evaluating tazemetostat in relapsed/refractory follicular lymphoma with EZH2 mutation has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy
A completed clinical trial investigated the role of large extracellular vesicles as biomarkers in various lymphomas and lymphoproliferative …
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial update on locally manufactured CAR T-cell products for multiple B-cell malignancies, including B-cell lymphoma and B-…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas [Phase 2]
A Phase 2 study evaluating the triple combination therapy DTRM-555 in relapsed/refractory chronic lymphocytic leukemia and relapsed/refracto…
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma [Phase 2]
A Phase 2 clinical trial investigating Zuberitamab in combination with bendamustine, followed by maintenance, for treatment-naïve follicular…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors [Phase 1, Phase 2]
An update on the Phase 1/2 study of CYT-0851 in B-cell malignancies and advanced solid tumors, noting completion of Phase 1/2 cohorts.
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: The Microbiome in Blood Cancer and HLH
A clinical trial update from University of Nottingham examining the microbiome's role in blood cancers and haemophagocytic lymphohistiocytos…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas [Phase 1]
Phase 1 trial evaluating SD-101 (TLR9 agonist) and BMS-986178 (anti-OX40 antibody) with radiation therapy for low-grade B-cell non-Hodgkin l…